Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer

dc.creatorLIMA, Eleonidas Moura
dc.creatorLEAL, Mariana Ferreira
dc.creatorBURBANO, Rommel Mario Rodriguéz
dc.creatorKHAYAT, André Salim
dc.creatorASSUMPÇÃO, Paulo Pimentel de
dc.creatorBELLO, Maria Josefa
dc.creatorHERRANZ, Juan Antonio Rey
dc.creatorSMITH, Marília de Arruda Cardoso
dc.creatorCASARTELLI, Cacilda
dc.date.accessioned2013-02-05T13:29:23Z
dc.date.available2013-02-05T13:29:23Z
dc.date.issued2008-06
dc.description.abstractGastric cancer is the forth most frequent malignancy and the second most common cause of cancer death worldwide. DNA methylation is the most studied epigenetic alteration, occurring through a methyl radical addition to the cytosine base adjacent to guanine. Many tumor genes are inactivated by DNA methylation in gastric cancer. We evaluated the DNA methylation status of ANAPC1, CDKN2A and TP53 by methylation-specific PCR in 20 diffuse- and 26 intestinal-type gastric cancer samples and 20 normal gastric mucosa in individuals from Northern Brazil. All gastric cancer samples were advanced stage adenocarcinomas. Gastric samples were surgically obtained at the João de Barros Barreto University Hospital, State of Pará, and were stored at -80°C before DNA extraction. Patients had never been submitted to chemotherapy or radiotherapy, nor did they have any other diagnosed cancer. None of the gastric cancer samples presented methylated DNA sequences for ANAPC1 and TP53. CDKN2A methylation was not detected in any normal gastric mucosa; however, the CDKN2A promoter was methylated in 30.4% of gastric cancer samples, with 35% methylation in diffuse-type and 26.9% in intestinal-type cancers. CDKN2A methylation was associated with the carcinogenesis process for ~30% diffuse-type and intestinal-type compared to non-neoplastic samples. Thus, ANAPC1 and TP53 methylation was probably not implicated in gastric carcinogenesis in our samples. CDKN2A can be implicated in the carcinogenesis process of only a subset of gastric neoplasias.pt_BR
dc.identifier.citationLIMA, E. M. et al. Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer. Brazilian Journal of Medical and Biological Research. Ribeirão Preto, v. 41, n. 6, p. 539-543, jun. 2008. Disponível em: <http://www.scielo.br/pdf/bjmbr/v41n6/7136.pdf>. Acesso em: 31 jan. 2013. <http://dx.doi.org/10.1590/S0100-879X2008000600017>.pt_BR
dc.identifier.issn0100-879X
dc.identifier.urihttps://repositorio.ufpa.br/handle/2011/3439
dc.language.isoengpt_BR
dc.rightsAcesso Aberto
dc.subjectMetilação de DNApt_BR
dc.subjectNeoplasias gástricaspt_BR
dc.subjectANAPC1pt_BR
dc.subjectCDKN2Apt_BR
dc.subjectTP53pt_BR
dc.titleMethylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancerpt_BR
dc.typeArtigo de Periódico

Arquivo(s)

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
Artigo_MethylationStatusANAPC1.pdf
Tamanho:
498.01 KB
Formato:
Adobe Portable Document Format

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.95 KB
Formato:
Item-specific license agreed upon to submission
Descrição: